Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies

Heart

Volumn 90, Issue 8, 2004, Pages 921-926

  Carvalho, J S ^a,b   Moscoso, G ^b   Tekay, A ^b   Campbell, S ^b   Thilaganathan, B ^b   Shinebourne, E A ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA ARCH; ARTICLE; CADAVER; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; ECHOCARDIOGRAPHY; FAMILY; FEMALE; FETUS; FETUS DEATH; FOLLOW UP; GESTATIONAL AGE; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PREGNANCY; HUMAN; PERINATAL PERIOD; PREGNANCY TERMINATION; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; SECOND TRIMESTER PREGNANCY; SITUS INVERSUS; STRESS;

ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FETAL HEART; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; ULTRASONOGRAPHY, PRENATAL;

EID: 3442891536     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.015065     Document Type: Article

References (14)

1. Carvalho JS, Moscoso G, Ville Y. First-trimester transabdominal fetal echocardiography. Lancet 1998;351:1023-7.
2. Huggon IC, Ghi T, Cook AC, et al. Fetal cardiac abnormalities identified prior to 14 weeks gestation. Ultrasound Obstet Gynecol 2002;20:22-9.
3. Hyett J, Moscoso G, Nicolaides K. Increased nuchal translucency in trisomy 21 fetuses: relationship to narrowing of the aortic isthmus. Hum Reprod 1995;10:3049-51.
4. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
5. Shinebourne EA, Macartney FJ, Anderson RH. Sequential chamber localization: a logical approach to diagnosis in congenital heart disease. Br Heart J 1976;38:327-40.
6. Anon. Review of the guidance on the research use of fetuses and fetal material (Polkinghorne report). London: Her Majesty's Stationery Office, 1989.
7. Moscoso G, Pexieder T. Variations in microscopic anatomy and ultrastructure of human embryonic hearts subjected to three different modes of fixation. Pathol Res Pract 1990;186:768-74.
8. Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-9.
9. Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-6.
10. Hyett JA, Perdu M, Sharland GK, et al. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997;10:242-6.
11. Mavrides E, Cobian-Sanchez F, Tekay A, et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17:106-10.
12. Ghi T, Huggon IC, Zosmer N, et al. Incidence of major structural heart defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001;18:610-4.
13. Yagel S, Weissman A, Rotstein Z, et al. Congenital heart defects: natural course and in utero development. Circulation 1997;96:550-5.
14. Bronshtein M, Zimmer EZ, Gerlis LM, et al. Early ultrasound diagnosis of fetal small left ventricle with a normal proximal outlet tract: a medical dilemma. Prenat Diagn 1997;17:249-53.